![BHP says long-term Chair Ken MacKenzie to leave, Ross McEwan to take over](https://i-invdn-com.investing.com/news/LYNXNPEC1N0C7_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.760 | 2.760 | 0.000 |
Stocks | 96.820 | 96.820 | 0.000 |
Preferred | 0.200 | 0.200 | 0.000 |
Other | 0.220 | 0.220 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.049 | 18.243 |
Price to Book | 3.154 | 3.706 |
Price to Sales | 5.022 | 5.368 |
Price to Cash Flow | 11.549 | 13.402 |
Dividend Yield | 0.571 | 0.517 |
5 Years Earnings Growth | 6.555 | 20.427 |
Number of long holdings: 91
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amgen | US0311621009 | 6.05 | 295.06 | -0.54% | |
Vertex | US92532F1003 | 5.82 | 453.20 | -0.44% | |
Gilead | US3755581036 | 5.64 | 103.31 | +7.46% | |
Regeneron Pharma | US75886F1075 | 5.57 | 663.86 | -0.24% | |
Intracellular Th | US46116X1019 | 3.73 | 127.97 | +0.32% | |
argenx ADR | US04016X1019 | 3.51 | 649.09 | +2.06% | |
Jazz Pharma | IE00B4Q5ZN47 | 3.36 | 135.44 | +4.20% | |
Neurocrine | US64125C1099 | 2.86 | 117.18 | +0.28% | |
AstraZeneca ADR | US0463531089 | 2.83 | 74.43 | +2.34% | |
Merus | NL0011606264 | 2.65 | 40.26 | +0.37% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Technology Fund X acc USD | 10.8M | 27.53 | 2.87 | 18.77 | ||
Franklin Technology Fund C acc USD | 205.05M | 24.98 | 0.60 | 16.18 | ||
Franklin Technology Fund I acc USD | 1.12B | 26.71 | 2.15 | 17.94 | ||
Franklin Technology Fund W acc USD | 486.74M | 26.68 | 2.11 | 17.86 | ||
Franklin Technology Fund Z acc USD | 30.73M | 26.66 | 2.89 | 17.59 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review